FitLife Brands, Inc. - Common Stock (NQ:FTLF)

8.400 +0.050 (+0.60%)

Delayed Quote Updated: 11:19 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about FitLife Brands, Inc. - Common Stock

< Previous 1 2 Next >

FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds ↗

October 24, 2026

FitLife Brands (NASDAQ:FTLF) outlined its strategy to grow a portfolio of nutritional supplement and wellness brands through acquisitions, e-commerce sales and operational improvements, while...

Via MarketBeat

Topics Intellectual Property

FitLife Brands (FTLF) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Irwin integration drives 65% revenue growth amid specialty retail headwinds.

Via The Motley Fool

Topics Earnings

FitLife Brands Q2 Earnings Call Highlights ↗

August 13, 2026

FitLife Brands (NASDAQ:FTLF) reported second-quarter 2026 revenue of $26.5 million, up 65% from a year earlier, as the company’s acquisition of Irwin Naturals more than offset declines in its Legacy...

Via MarketBeat

Topics Earnings

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

A Peek at FitLife Brands's Future Earnings ↗

August 13, 2025

Via Benzinga

Insights into FitLife Brands's Upcoming Earnings ↗

May 14, 2025

Via Benzinga

FitLife (FTLF) Q4 2025 Earnings Call Transcript ↗

May 28, 2026

FitLife (FTLF) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

FitLife (FTLF) Q1 2026 Earnings Call Transcript ↗

May 15, 2026

FitLife (FTLF) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

FitLife Brands Q1 Earnings Call Highlights ↗

May 14, 2026

FitLife Brands (NASDAQ:FTLF) reported sharply higher first-quarter 2026 revenue, driven by the acquisition of Irwin, while profitability declined as the company absorbed lower Irwin margins and higher...

Via MarketBeat

Topics Earnings

Colgate-Palmolive Stock Earns RS Rating Upgrade ↗

October 09, 2024

Colgate-Palmolive stock had its Relative Strength (RS) Rating to 81 on Wednesday, up from 78 a day earlier.

Via Investor's Business Daily

FTLF Stock Earnings: FitLife Brands Reported Results for Q2 2024 ↗

August 20, 2024

FitLife Brands just reported results for the second quarter of 2024.

Via InvestorPlace

Earnings Outlook For FitLife Brands ↗

November 12, 2025

Via Benzinga

FitLife Brands Inc (NASDAQ:FTLF) Reports Mixed Q2 2025 Results: Revenue Misses, EPS Beats Estimates ↗

August 14, 2025

FitLife Brands Q2 2025 earnings miss revenue estimates but beat EPS. Revenue fell 5% YoY to $16.1M, while adjusted EPS was $0.18. Stock up 30.5% in two weeks.

Via Chartmill

Topics Earnings

FitLife Brands Reports 5 Percent Q2 Drop ↗

August 14, 2025

Via The Motley Fool

Topics World Trade

FitLife Brands Inc (NASDAQ:FTLF) Stands Out as a High-Quality Pick in the Caviar Cruise Screen ↗

August 06, 2025

FitLife Brands (FTLF) excels in quality investing with high ROIC, strong margins, and steady growth, making it a top pick for long-term portfolios.

Via Chartmill

Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

February 07, 2025

Via Benzinga

e.l.f. Beauty Stock Earns 93 RS Rating; Profits Surge ↗

May 24, 2024

On Friday, cosmetic e.l.f. Beauty stock had its Relative Strength (RS) Rating upgraded to 93 from 85 a day earlier.

Via Investor's Business Daily

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Oddity Tech Stock Earns Relative Strength Rating Upgrade ↗

December 09, 2024

On Monday, Oddity Tech stock hit a key performance benchmark, seeing its Relative Strength Rating jump to 81, up from 76 the day before.

Via Investor's Business Daily

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

FitLife Brands Poised For Strong Revenue Growth, Cost Savings: Analyst ↗

September 03, 2024

Roth Capital Partners analyst Sean McGowan initiated coverage of FitLife Brands with a Buy rating and a price target of $40.

Via Benzinga

2 Small Caps Recently Upgraded To Outperform - Sunday, Sept. 1 ↗

September 01, 2024

Here is a brief look at two small cap stocks that have recently been upgraded due to their performance and strategy execution.

Via Talk Markets

3 Unknown Small-Cap Gems That Could Explode 900% by 2026 ↗

August 03, 2024

These three unknown small-cap stocks with solid profitability could potentially deliver returns of up to 900% by 2026.

Via InvestorPlace

Top Analyst Reports For AMD, PepsiCo & SAP ↗

May 21, 2024

Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc., PepsiCo, Inc., and SAP SE, as well as two micro-cap stocks FitLife Brands, Inc. and...

Via Talk Markets

Colgate-Palmolive Stock Acts Like Young Growth Company; Earns 81 RS Rating ↗

May 08, 2024

Colgate-Palmolive stock trades well above its 21-day, 50-day and 200-day lines after a strong seven-month run.

Via Investor's Business Daily

Colgate-Palmolive Stock, A Steady Eddie Grower, Tops Benchmark ↗

May 01, 2024

The upgraded 81 Relative Strength Rating shows Colgate-Palmolive stock tops 81% of stocks in IBD's database for performance this past year.

Via Investor's Business Daily

Colgate-Palmolive Stock Sees Relative Strength Rating Climb To 72 ↗

February 21, 2024

Colgate-Palmolive stock had its Relative Strength Rating climb to 72 Wednesday -- a nice improvement, but shy of the preferred 80-plus score.

Via Investor's Business Daily

e.l.f. Beauty Stock Earns Membership In 95-Plus Composite Rating Club ↗

November 15, 2023

e.l.f. Beauty saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, up from 92 the day before.

Via Investor's Business Daily

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.